Millennium Pharmaceuticals

News Millennium Pharmaceuticals

• Approved lymphoma drug shows promise in early tests against bone cancer

  A drug already approved for the treatment of lymphoma may also slow the growth of the most deadly bone cancer in children and teens, according to an early-stage study published in the International Journal of Cancer. The study drug, Bortezomib, was found to be effective against bone cancer in human more

• Research and Markets: Company and Industry Analysis of the US $ 14.9 Billion Asia-Pacific Biotechnology Market

  Research and Markets has announced the addition of the "Asia-Pacific Biotechnology Sectors : A Company and Industry Analysis" report to their offering. This report updates the previous Asia-Pacific biotechnology report, focusing on the markets in Australia, China and Hong Kong, India, Japan, South more

• ITI Life Sciences appoints Eleanor Mitchell as Managing Director

  ITI Life Sciences announced the appointment of Dr Eleanor Mitchell as Managing Director as part of the wider reorganisation of ITI Scotland, its parent group. Over the past 18 months, Dr Mitchell, in her former role of Acting CEO of ITI Life Sciences, has overseen the progression of the organisatio more

Market studies Millennium Pharmaceuticals

• Switzerland Pharmaceuticals and Healthcare Report Q3 2011

  BMI View: Despite the threat of austerity measures, the Swiss government’s focus on cost-containment within the pharmaceuticals and healthcare sector and the impact of generic competition as a result of the patent cliff, we expect Switzerland to remain attractive to innovative drugmakers. Furthermor more

• Acute Coronary Syndrome (ACS) Drug Market Prospects 2011-2021

  What are the commercial prospects for the pharmacological treatment of acute coronary syndrome? Our new report shows you its revenue potential from 2011 to 2021. We predict and explain the commercial opportunities in that industry and market. Our report gives you revenue forecasts to 2021 for treat more

• Leading Anti-Cancer Drugs: World Market Prospects 2011-2021

  What will this decade hold for leading anti-cancer drugs and that therapeutic market? Our new report shows you anti-cancer drug revenue forecasts for 2011 to 2021. We provide research, data and opinions to benefit your work now. What revenues will cancer treatment markets generate from 2011 to 2021 more

Websites Millennium Pharmaceuticals